David it Up! @david.notesforfriends.com · Dec 26 Seriously, we need a much more effective SARS-COV-2 antivirals and monoclonal antibodies! It’s ridiculous to say it can’t be viral persistence, when a medication, a monoclonal antibody designed for earlier variants improves many Long Covid patients! (1/4)
72 likes 2 replies
?
Replies
If it improved their Long Covid symptoms from a variant it’s close to, it’s likely a persistent version of that, thus pointing to a persisting version the drug matched. (2/4)
There’s a new *broad spectrum antiviral* drug: a methyltransferase inhibitor